Prognostic Impact of Hematopoietic Recovery After Fludarabine, IV Busulfan and Antithymocyte Globulins (FB2 regimen) Reduced-Intensity Conditioning Regimen (RIC) Allogeneic Stem Cell Transplantation (allo-SCT)
Year: 2012
Type: article
Study design: Observational Study
Source: Blood
Authors: Amandine Lebourgeois, Marion Loirat, Benoit Tessoulin, Elsa Lestang, Pierre Peterlin, Florent Malard, Catherine Mohr, Cyrille Touzeau, Nicolas Blin, Aline Clavert, Karine Augeul-Meunier, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Eolia Brissot, Viviane Dubruille, Beatrice Mahe, Virginie Roland, Thomas Gastinne, Steven Le Gouill, Philippe Moreau, Mohamad Mohty, Lucie Planche, Patrice Chevallier
Institutions: Centre Hospitalier Universitaire de Nantes, Nantes Université
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: reduced-intensity conditioning, allogeneic stem cell transplantation, fludarabine, busulfan, antithymocyte globulin, hematopoietic recovery, graft-versus-host disease, graft-versus-leukemia effect, relapse, progression-free survival, leukemia-free survival, myelodysplastic syndrome, multiple myeloma, acute myeloid leukemia
Open Access status: closed
OpenAlex ID: W2586355990
